Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations
Moderna (MRNA) shares fell as a lot as 25% on Thursday, regardless of optimistic most cancers vaccine information. The shot minimize melanoma recurrence or loss of life threat by 42% in sure sufferers. Partial information leaked earlier than the total launch. Even after the drop, the inventory was up greater than 530% for 2026 as…
